Security Snapshot

BRIGHTSPRING HEALTH SVCS INC - UNIT 02/01/2027 Institutional Ownership

CUSIP: 10950A205

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

2

Shares (Excl. Options)

643,185

Price

$142.27

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / UNIT 02/01/2027
Price per share
$142.27
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
643,185
Total reported value
$91,518,209
Share change
0
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • 10950A205 - BRIGHTSPRING HEALTH SVCS INC - UNIT 02/01/2027 is tracked under CUSIP 10950A205.
  • 2 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $13,123,743 to $91,518,209.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 2 institutions filings for Q1 2026.

Open SEC Evidence

Security key

10950A205

Latest holder period

Q1 2026

13F holders

2

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 2 institutional investors reported holding 643,185 shares of BRIGHTSPRING HEALTH SVCS INC - UNIT 02/01/2027.

Institutional Holders of BRIGHTSPRING HEALTH SVCS INC - UNIT 02/01/2027 across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 643,185 $91,518,209 $142.27 2
2025 Q4 103,745 $13,123,743 -$170,902 $126.50 1
2024 Q3 123,000 $6,931,050 +$450,800 $56.35 1
2024 Q2 885,819 $41,558,650 -$319,334 $46.48 2
2024 Q1 894,019 $40,153,607 +$40,153,607 $44.64 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .